Susquehanna International Group, LLP Bioventus Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.73 - $11.95 $189,663 - $395,545	33,100 Added 25.27%	164,100 $1.96 Million
Q2 2024 Aug 15, 2024	SELL	$3.96 - $6.93 $118,800 - $207,900	-30,000 Reduced 18.63%	131,000 $753,000
Q1 2024 May 07, 2024	SELL	$4.33 - $5.75 $59,321 - $78,775	-13,700 Reduced 7.84%	161,000 $837,000
Q4 2023 Feb 14, 2024	SELL	$2.89 - $5.34 $34,680 - $64,080	-12,000 Reduced 6.43%	174,700 $920,000
Q3 2023 Nov 14, 2023	BUY	$2.8 - $4.94 $120,959 - $213,408	43,200 Added 30.1%	186,700 $616,000
Q2 2023 Aug 11, 2023	BUY	$0.93 - $3.64 $133,455 - $522,340	143,500 New	143,500 $414,000
Q3 2022 Nov 14, 2022	SELL	$6.54 - $9.08 $9,810 - $13,620	-1,500 Reduced 11.63%	11,400 $80,000
Q2 2022 Aug 15, 2022	BUY	$6.82 - $13.82 $87,978 - $178,278	12,900 New	12,900 $88,000

142

45.9M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $729M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.